Inorganic Chemistry
Article
1
diastereomer (16%), H NMR (300 MHz, C6D6, 25 °C): δ 0.87 (t,
indicated the quantitative formation of the new Rh(I) complex 2b
(broad signal at δ 60.3), and the diastereomeric ratio was estimated
from the 13C NMR spectrum (65/35). All volatiles were removed in
vacuo, and yellow crystals suitable for an X-ray diffraction analysis were
obtained from a CH2Cl2−Et2O solution at −30 °C. Major
3JHH = 7.3 Hz, 3H, CH3Bu), 0.98 (d, 3JHH = 6.7 Hz, 3H, CH3PNiPr), 1.06
(d, JHH = 6.6 Hz, 3H, CH3PNiPr), 1.13 (d, JHH = 6.6 Hz, 3H,
CH3PNiPr), 1.15 (d, JHH = 6.7 Hz, 3H, CH3PNiPr), 1.22 (d, JHH = 6.7
Hz, 3H, CH3iPr), 1.24 (overlapped with the methyl signal, 2H,
GeCH2CH2Bu), 1.25 (overlapped with the methyl signal, 1H, 1/2
CH2bridge), 1.26 (d, 3JHH = 6.9 Hz, 3H, CH3iPr), 1.33 (d, 3JHH = 6.8 Hz,
3H, CH3iPr), 1.38−1.45 (m, 3H, 1/2 CH2CbridgeheadCN, CH2CH3Bu),
1.51 (d, 3JHH = 6.7 Hz, 3H, CH3iPr), 1.52 (overlapped with the methyl
3
3
3
3
1
diastereomer (65%), H NMR (300 MHz, CDCl3, 25 °C): δ 0.94
(d, 3JHH = 6.8 Hz, 3H, CH3iPr), 1.03 (d, 3JHH = 6.5 Hz, 6H, CH3PNiPr),
1.14 (d, 3JHH = 6.7 Hz, 3H, CH3iPr), 1.15 (overlapped with the methyl
3
signal, 1H, 1/2 CH2CbridgeheadCP), 1.18 (d, JHH = 6.6 Hz, 3H,
n
CH3PNiPr), 1.44 (m, 4H, CH2bridge, 1/2 CH2CbridgeheadCP, 1/2
signal, 2H, 1/2 CH2CbridgeheadCN, 1/2 GeCH2 Bu), 1.54−1.64 (m, 2H,
3
CH2CbridgeheadCN), 1.69 (d, JHH = 6.8 Hz, 12H, CH3PNiPr, 2CH3iPr),
1/2 CH2CbridgeheadCP, 1/2 GeCH2Bu), 1.76−185 (m, 2H, 1/2
CH2CbridgeheadCP, 1/2 CH2bridge), 2.44 (brs, 1H, PCCHbridgehead), 2.54−
2.65 (m, 2H, PNCH2), 2.69−2.80 (m, 2H, PNCH2), 2.88 (brs, 1H,
NCCHbridgehead), 3.29 (sept, 3JHH = 6.6 Hz, 1H, CHiPr), 3.56−3.65 (m,
1.70 (overlapped with the methyl signal, 1H, 1/2 CH2CbridgeheadCN),
1.98 (m, 4H, PNCH2), 2.28 (m, 4H, PNCH2), 2.62 (br s, 1H,
PCCHbridgehead), 2.70 (m, 1H, CHiPr), 2.93 (brs, 1H, NCCHbridgehead),
2.98−3.09 (m, 4H, 2 PNCH2), 3.17−3.23 (m, 2H, PNCHiPr), 3.29 (m,
1H, CHiPr), 4.96, 5.07 (2xbrs, 4H, CHCHCOD), 6.96 (m, 5H, HAr),
7.22 (m, 3H, HAr). 13C{1H} NMR (75.5 MHz, CDCl3, 25 °C): δ 20.3
(s, CH3PNiPr), 21.1 (d, 3JPC = 2.5 Hz, CH3PNiPr), 21.4 (d, 3JPC = 8.6 Hz,
3
1H, PNCHiPr), 3.76 (sept, JHH = 6.9 Hz, 1H, CHiPr), 3.91−4.00 (m,
1H, PNCHiPr), 7.13−7.17 (m, 3H, HAr). 13C{1H} NMR (75.5 MHz,
2
C6D6, 25 °C): δ 13.9 (s, CH3 Bu), 19.3 (d, JPC = 2.1 Hz, GeCH2Bu),
3
3
19.8 (d, JPC = 1.4 Hz, CH3PNiPr), 20.1 (d, JPC = 1.5 Hz, CH3PNiPr),
3
3
3
CH3PNiPr), 21.8 (d, JPC = 1.7 Hz, CH3PNiPr), 22.5 (s, CH3iPr), 25.2 (s,
21.2 (d, JPC = 6.4 Hz, CH3PNiPr), 21.4 (d, JPC = 3.1 Hz, CH3PNiPr),
3
CH3iPr), 25.5 (s, CH3iPr), 25.7 (s, CH3iPr), 26.8 (s, CH2COD), 27.4 (s,
CH2COD), 27.5 (s, CHiPr), 27.8 (s, CHiPr), 29.0 (s, CH2COD), 29.4 (s,
CH2COD), 32.3 (s, CH2CbridgeheadCN), 34.8 (s, CH2CbridgeheadCP), 39.0
24.4 (s, CH3iPr), 24.7 (s, CH3iPr), 24.6 (s, CH3iPr), 25.6 (d, JHP = 1.3
n
Hz, 3H, GeCH2CH2 Bu), 26.2 (d, JPC = 2.7 Hz, CH3iPr), 26.8 (s,
3
CH2CbridgeheadCN), 27.4 (s, CHiPr), 28.26 (s, CHiPr), 30.1 (d, JPC = 0.9
(brs, PNCH2), 40.9 (d, 3JPC = 4.6 Hz, NCCHbridgehead), 43.9 (d, 2JPC
6.3 Hz, PNCHiPr), 44.1 (d, JPC = 9.6 Hz, PNCHiPr), 45.2 (d, JPC
=
=
n
Hz,CH2CbridgeheadCP), 30.6 (d, 4JHP = 9.8 Hz, 3H, CH2CH3 Bu), 39.0 (d,
2
2
2JPC = 2.5 Hz, PNCH2), 39.2 (d, 2JPC = 1.5 Hz, PNCH2), 40.9 (d, 3JPC
2
9.1 Hz, PCCHbridgehead), 46.4 (brs, CH2bridge), 63.2 (brs, HCCHCOD),
65.1 (brs, HCCHCOD), 91.5 (d, JPC = 51.4 Hz, PCCN), 98.8 (m,
HCCHCOD), 99.6 (d, JRhC = 7.3 Hz, HCCHCOD), 123.5, 124.5,
126.3, 126.9, 127.6 (CHAr), 134.3 (d, 3JPC = 6.4 Hz, GeCHortho), 139.7
= 7.8 Hz, NCCHbridgehead), 43.4 (d, JPC = 13.5 Hz, PCCHbridgehead),
43.9 (d, JPC = 6.4 Hz, PNCHiPr), 44.7 (d, JPC = 11.3 Hz, PNCHiPr),
2
2
3
48.9 (d, JPC = 3.0 Hz, CH2bridge), 92.0 (d, JPC = 30.2 Hz, PCCN),
3
123.4, 123.9, 126.1 (CHAr), 141.6 (d, JPC = 5.2 Hz, NCipso), 145.9,
(s, NCipso), 140.2 (brs, GeCipso), 147.4, 147.9 (NCortho),190.7 (d, 2JPC
=
147.3 (NCortho), 186.8 (d, JPC = 40.2 Hz, PCCN). 31P{1H} NMR
2
32.4 Hz, PCCN). 31P{1H} NMR (121.5 MHz, CDCl3, 25 °C): δ
60.3 (br). Minor diastereomer (35%), 13C{1H} NMR (75.5 MHz,
CDCl3, 25 °C): δ 19.4 (d, 3JPC = 3.0 Hz, CH3PNiPr), 20.1 (d, 3JPC = 6.3
Hz, CH3PNiPr), 20.9 (s, 2C, CH3PNiPr), 22.3 (s, CH3iPr), 25.0 (s,
CH3iPr), 26.0 (s, CH3iPr), 26.1 (s, CH3iPr), 28.0 (s, CHiPr), 28.1 (s,
CHiPr), 29.4 (s, CH2COD), 29.7 (s, CH2COD), 30.5 (s, CH2COD), 31.0 (s,
CH2CbridgeheadCN), 31.1 (s, CH2COD), 35.9 (s, CH2CbridgeheadCP), 37.0 (d,
2JPC = 7.1 Hz, PNCH2), 37.9 (d, 2JPC = 6.2 Hz, PNCH2), 39.5 (d, 3JPC
= 3.7 Hz, NCCHbridgehead), 45.0 (d, 2JPC = 8.1 Hz, PNCHiPr), 46.4 (brs,
(121.5 MHz, C6D6, 25 °C): δ 80.9. Anal. calcd for C31H52N3PGe: C,
65.28; H, 9.19; N, 7.37. Found: C, 65.60; H, 9.21; N, 7.40.
Synthesis of Metallacycle 3a. To a THF solution (7 μL) of
[Rh2(μ-Cl)2(COD)2] (30.0 mg, 0.062 mmol) was added, at RT, 1a
(66 mg, 0.121 mmol), and the reaction mixture was stirred for 2 h.
Crystals suitable for an X-ray diffraction analysis were obtained from a
1
saturated THF solution at −30 °C (62.0 mg, 65%). H NMR (300
MHz, C6D6, 25 °C): δ 0.71 (d, JHH = 8.2 Hz, 1H, 1/2 CH2bridge), 1.15
(d, JHH = 6.5 Hz, 3H, CH3PNiPr), 1.18 (d, JHH = 6.7 Hz, 3H, CH3PNiPr),
1.17 (overlapped with the methyl signal, 1H, 1/2 CH2bridge), 1.27 (d,
JHH = 6.9 Hz, 3H, CH3iPr), 1.29 (d, JHH = 6.9 Hz, 3H, CH3iPr), 1.33 (d,
JHH = 6.4 Hz, 3H, CH3PNiPr), 1.45 (d, JHH = 6.8 Hz, 3H, CH3iPr), 1.48
(d, JHH = 6.4 Hz, 3H, CH3PNiPr), 1.55 (m, 3H, CH2CbridgeheadCP, 1/2
CH2CbridgeheadCN), 1.69 (d, JHH = 6.6 Hz, 3H, CH3iPr), 1.68 (overlapped
with the methyl signal, 1H, 1/2 CH2CbridgeheadCN), 1.76−2.11 (m, 8H,
4CH2COD), 2.53 (m, 1H, PCCHbridgehead), 2.58−2.66 (m, 2H, PNCH2),
2.77−2.85 (m, 3H, NCCHbridgehead, PNCH2), 3.26 (m, 1H, PNCHiPr),
3.70 (sept, JHH = 6.8 Hz, 1H, CHiPr), 4.13 (sep, JHH = 6.7 Hz, 1H,
CHiPr), 4.30 (m, 1H, PNCHiPr), 4.80, 4.91 (2xbrs, 2H, CHCHCOD),
5.45, 5.79 (2xbrs, 2H, CHCHCOD), 7.17−7.28 (m, 3H, HAr).
2
2
CH2bridge), 47.2 (d, JPC = 9.2 Hz, PCCHbridgehead), 47.5 (d, JPC = 7.7
Hz, PNCHiPr), 60.2 (d, JRhC = 13.3 Hz, HCCHCOD), 67.2 (d, JRhC
=
13.7 Hz, HCCHCOD), 90.0 (d, JPC = 52.6 Hz, PCCN), 97.1 (d,
JRhC = 8.1 Hz, HCCHCOD), 97.5 (d, JRhC = 6.1 Hz, HCCHCOD),
123.9, 124.1, 128.0, 128.1, 128.6 (CHAr), 134.3 (d, 3JPC = 6.4 Hz, 2C,
GeCHortho), 139.7 (s, NCipso), 140.0 (brs, GeCipso), 146.2, 146.6
2
(NCortho), 192.6 (d, JPC = 32.4 Hz, PCCN). 31P{1H} NMR (121.5
MHz, CDCl3, 25 °C): δ 60.3 (br).
Synthesis of Dimethylbutadiene Cycloadduct 4. To a C6D6
solution (0.5 mL) of 1c (50 mg, 0.095 mmol), at room temperature,
was added 2,3-dimethyl-1,3-butadiene (21.4 μL, 0.189 mmol). The
solution was warmed at 65 °C for 72 h. All volatiles were removed in
vacuo, and the product was obtained as yellow oil and was analyzed
13C{1H} NMR (75.5 MHz, C6D6, 25 °C): δ 21.6 (d, JPC = 5.4 Hz,
3
3
3
CH3PNiPr), 22.0 (d, JPC = 5.5 Hz, CH3PNiPr), 22.4 (d, JPC = 2.5 Hz,
1
3
without any further purification. H NMR (300 MHz, C6D6, 25 °C):
CH3PNiPr), 22.9 (d, JPC = 6.0 Hz, CH3PNiPr), 24.6 (s, CH3iPr), 24.8 (s,
CH3iPr), 25.8 (s, CH3iPr), 26.1 (d, 4JPC = 1.2 Hz, CH2CbridgeheadCN), 28.0
the most representative signals δ 0.48 (brs, 3H, GeCH3), 1.47 (brs,
3H, CH3vinyl), 1.47 (brs, 1H, 1/2CH2vinyl), 1.66 (brs, 3H,
CH3vinyl), 1.70 (brs, 3H, 3/2CH2vinyl). 13C{1H} NMR (75.5 MHz,
C6D6, 25 °C): δ 1.1 (s, GeCH3), 19.2 (s, 2C, CH3vinyl), 22.0 (d, 3JPC
= 15.2 Hz, 2C, CH3PNiPr), 22.2 (d, 3JPC = 10.6 Hz, CH3PNiPr), 22.8 (d,
3JPC = 11.8 Hz, CH3PNiPr), 23.1 (s, CH3iPr), 23.3 (s, CH3iPr), 23.4 (s,
CH3iPr), 23.5 (s, CH3iPr), 25.9 (s, CH2CbridgeheadCN), 27.6 (s, CHiPr),
2
(s, CHiPr), 28.2 (s, CHiPr), 28.3 (s, CH2CbridgeheadCP), 29.1 (d, JRhC
=
=
2
2
2.1 Hz, CH2COD), 29.7 (d, JRhC = 1.8 Hz, CH2COD), 30.6 (d, JRhC
3.2 Hz, CH2COD), 30.9 (d, 2JRhC = 1.4 Hz, CH2COD), 39.9 (d, 2JPC = 1.7
3
2
Hz, PNCH2), 42.7 (d, JPC = 3.6 Hz, CH2bridge), 44.9 (d, JPC = 13.4
Hz, PNCHiPr), 45.8 (d, 3JPC = 1.7 Hz, NCCHbridgehead), 45.9 (d, 2JPC
=
1.2 Hz, PNCH2), 47.2 (d, 2JPC = 6.3 Hz, PNCHiPr), 48.2 (d, 2JPC = 8.2
Hz, PCCHbridgehead), 94.7 (d, JRhC = 8.2 Hz, HCCHCOD), 96.2 (t,
JRhC = 2.7 Hz, HCCHCOD), 96.4 (d, JRhC = 5.9 Hz, HCCHCOD),
100.3 (dd, JRhC = 6.2 Hz, 2JPC = 10.2 Hz, HCCHCOD), 105.2 (dd, JPC
27.7 (s, CHiPr), 28.6 (s, 3C, CH2CbridgeheadCP, CH2vinyl), 43.7 (d, 2JPC
=
1.6 Hz, PCCHbridgehead), 44.3 (d, 3JPC = 3.7 Hz, CH2bridge), 44.8 (d, 2JPC
= 22.6 Hz, PNCHiPr), 49.4 (d, 2JPC = 8.7 Hz, PNCH2), 49.7 (d, 2JPC
=
=
2
3
2
15.0 Hz, PNCHiPr), 50.1 (d, JPC = 6.7 Hz, PNCH2), 51.4 (d, JPC
= 40.3 Hz, JRhC = 7.3 Hz, PCCN), 123.3, 124.2, 126.9 (CHAr),
140.3 (NCipso), 147.2, 148.8 (NCortho), 174.6 (d, 2JPC = 17.8 Hz, PC
22.1 Hz, NCCHbridgehead), 106.6 (d, JPC = 33.0 Hz, PCCN), 123.1,
CN). 31P{1H} NMR (121.5 MHz, C6D6, 25 °C): δ 61.7 (d, JPRh
=
123.3, 126.3 (CHAr), 129.9, 130.0 (brs, 2C, CC), 137.1 (s, 2C,
2
NCortho), 147.2 (brs, NCipso), 158.9 (d, JPC = 5.5 Hz, PCCN).
153.9 Hz).
31P{1H} NMR (121.5 MHz, C6D6, 25 °C): δ 84.5.
Synthesis of Rh(I) Complex 2b. To a THF solution (7 μL) of
[Rh2(μ-Cl)2(COD)2] (30.0 mg, 0.062 mmol) was added, at RT,
phenyl-substituted germylene 1b (71 mg, 0.121 mmol), and the
reaction mixture was stirred for 2 h at RT. The 31P NMR spectroscopy
Crystallographic Studies. Data for compounds 1a and 1b were
collected on a Bruker-AXS SMART APEX II diffractometer at 193(2)
K, with graphite-monochromated Mo Kα radiation (wavelength =
8189
dx.doi.org/10.1021/ic300600c | Inorg. Chem. 2012, 51, 8187−8193